Confirmed Sponsors 2019
The Congress Organizers would like to acknowledge the support of the following companies.
|For almost five decades, Elekta has been a leader in precision radiation medicine. Our nearly 4,000 employees worldwide are committed to ensuring everyone in the world with cancer has access to – and benefits from – more precise, personalized radiotherapy treatments. Our solutions for cancer care and brain disorders, including Elekta Unity MR-linac, Leksell Gamma Knife® Icon™ for intracranial radiosurgery and Versa HD™ HDRS platform are tailored to target the tumor and protect the patient. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm Exchange. Visit www.elekta.com or follow @Elekta on Twitter.|
Imagine a world free from the fear of cancer. We do, every day. That’s why at Varian, we’re obsessed with creating simpler, more efficient, and more effective technologies to power new victories in cancer care. The company’s Edge® system with HyperArc™ high-definition radiotherapy integrates imaging, positioning, motion management, and dose shaping technologies for treating abnormalities of the brain, spine, and other areas where radiosurgery is indicated. Varian is the long-standing global leader in comprehensive solutions for radiotherapy and radiosurgery, as well as software systems for managing cancer clinics, sharing knowledge and using data to deliver evidence-based medicine. Visit www.varian.com.
|BRAINLAB headquartered in Munich, develops, manufactures and markets software-driven medical technology, enabling access to advanced, less invasive patient treatments. Core products center on information-guided surgery, radiosurgery, precision radiation therapy, digital operating room integration, and information and knowledge exchange. Brainlab technology powers treatments in radiosurgery and radiotherapy as well as numerous surgical fields including neurosurgery, orthopedic, ENT, CMF, spine and trauma.
Privately held since its formation in Munich, Germany in 1989, Brainlab has more than 12,300 systems installed in over 100 countries. Brainlab employs more than 1,350 people in 18 offices worldwide, including more than 420 Research & Development engineers, who form a crucial part of the product development team.
|ACCURAY (NASDAQ: ARAY) develops, manufactures and sells radiotherapy systems that make cancer treatments shorter, safer, personalized and more effective, ultimately enabling patients to live longer, better lives. Our radiation treatment delivery systems in combination with fully-integrated software solutions set the industry standard for precision and cover the full range of radiation therapy and radiosurgery procedures.|
SPONSORS & EXHIBITORS
TOMMASO PRODUTOS E SERVICIOS